Literature DB >> 7819068

Homozygous beta-thalassaemia resulting in the beta-thalassaemia carrier state phenotype.

M C Rosatelli1, A Pischedda, A Meloni, L Saba, A Pomo, M Travi, S Fattore, A Cao.   

Abstract

This paper describes the phenotypic manifestations of a very mild beta-thalassaemia mutation detected in several members of two families of Italian descent. The molecular defect, defined by denaturing gradient gel electrophoresis analysis and direct sequencing, consists of a C-->G substitution at position 844 of IVSII of the beta-globin gene within the consensus sequence of the IVSII acceptor splice site. Heterozygotes for this mutation show a haematological phenotype ranging in severity from silent beta-thalassaemia to that of a mild beta-thalassaemia carrier state, whereas homozygotes have the typical manifestations commonly resulting from heterozygosity for a beta-thalassaemia mutation. Compound heterozygotes for the IVSII nt844 (C-->G) mutation and a severe beta-thalassaemia mutation have the phenotype of thalassaemia intermedia. This paper indicates that the presence of borderline red blood cell indices or HbA2 values should make one suspect the presence of a very mild or silent beta-thalassaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819068     DOI: 10.1111/j.1365-2141.1994.tb05074.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.

Authors:  André R Belisário; Anna B Carneiro-Proietti; Ester Cerdeira Sabino; Aderson Araújo; Paula Loureiro; Cláudia Máximo; Miriam V Flor-Park; Daniela D O W Rodrigues; Mina Cintho Ozahata; Christopher McClure; Rosimere Afonso Mota; Isabel C Gomes Moura; Brian Custer; Shannon Kelly
Journal:  Hemoglobin       Date:  2020-03-16       Impact factor: 0.849

2.  Very mild forms of Hb S/beta(+)-thalassemia in Brazilian children.

Authors:  André Rolim Belisário; Rahyssa Rodrigues Sales; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2015-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.